STUB1 and metabolic dysfunction-associated steatotic liver disease: In the TM-induced NAFLD model, intraperitoneal injection of TM induced liver steatosis in both CHIP+/+ and CHIP+/− mice, but it was severely exacerbated in CHIP+/− mice compared to CHIP+/+ mice.